Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 154

    1.

    Productivity and medical costs of diabetes in a large employer population.

    Ramsey S, Summers KH, Leong SA, Birnbaum HG, Kemner JE, Greenberg P.

    Diabetes Care. 2002 Jan;25(1):23-9.PMID: 11772896 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Economic costs of diabetes in the U.S. In 2007.

    American Diabetes Association.

    Diabetes Care. 2008 Mar;31(3):596-615. Review. Erratum in: Diabetes Care. 2008 Jun;31(6):1271. PMID: 18308683 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Economic burden of pneumonia in an employed population.

    Birnbaum HG, Morley M, Greenberg PE, Cifaldi M, Colice GL.

    Arch Intern Med. 2001 Dec 10-24;161(22):2725-31.PMID: 11732939 [PubMed - indexed for MEDLINE]Related articles

    4.

    Economic implications of treatment-resistant depression among employees.

    Greenberg P, Corey-Lisle PK, Birnbaum H, Marynchenko M, Claxton A.

    Pharmacoeconomics. 2004;22(6):363-73.PMID: 15099122 [PubMed - indexed for MEDLINE]Related articles

    5.

    Economic costs of diabetes in the US in 2002.

    Hogan P, Dall T, Nikolov P; American Diabetes Association.

    Diabetes Care. 2003 Mar;26(3):917-32.PMID: 12610059 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.

    Kleinman NL, Brook RA, Doan JF, Melkonian AK, Baran RW.

    J Clin Psychiatry. 2009 Aug;70(8):1098-104.PMID: 19758521 [PubMed - indexed for MEDLINE]Related articles

    7.

    Lower respiratory tract infections: impact on the workplace.

    Birnbaum H, Morley M, Leong S, Greenberg P, Colice G.

    Pharmacoeconomics. 2003;21(10):749-59. Erratum in: Pharmacoeconomics. 2003;21(12):883. PMID: 12828496 [PubMed - indexed for MEDLINE]Related articles

    8.

    Economic burden of respiratory infections in an employed population.

    Birnbaum HG, Morley M, Greenberg PE, Colice GL.

    Chest. 2002 Aug;122(2):603-11.PMID: 12171839 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    The economics of women and depression: an employer's perspective.

    Birnbaum HG, Leong SA, Greenberg PE.

    J Affect Disord. 2003 Mar;74(1):15-22.PMID: 12646295 [PubMed - indexed for MEDLINE]Related articles

    10.

    Health and productivity as a business strategy.

    Loeppke R, Taitel M, Richling D, Parry T, Kessler RC, Hymel P, Konicki D.

    J Occup Environ Med. 2007 Jul;49(7):712-21.PMID: 17622843 [PubMed - indexed for MEDLINE]Related articles

    11.

    Health and disability costs of depressive illness in a major U.S. corporation.

    Druss BG, Rosenheck RA, Sledge WH.

    Am J Psychiatry. 2000 Aug;157(8):1274-8.PMID: 10910790 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Economic cost and epidemiological characteristics of patients with fibromyalgia claims.

    Robinson RL, Birnbaum HG, Morley MA, Sisitsky T, Greenberg PE, Claxton AJ.

    J Rheumatol. 2003 Jun;30(6):1318-25.PMID: 12784409 [PubMed - indexed for MEDLINE]Related articles

    13.

    Economic impact of multiple sclerosis disease-modifying drugs in an employed population: direct and indirect costs.

    Birnbaum HG, Ivanova JI, Samuels S, Davis M, Cremieux PY, Phillips AL, Meletiche D.

    Curr Med Res Opin. 2009 Apr;25(4):869-77.PMID: 19232041 [PubMed - indexed for MEDLINE]Related articles

    14.

    The economic consequences of irritable bowel syndrome: a US employer perspective.

    Leong SA, Barghout V, Birnbaum HG, Thibeault CE, Ben-Hamadi R, Frech F, Ofman JJ.

    Arch Intern Med. 2003 Apr 28;163(8):929-35.PMID: 12719202 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies.

    Wu EQ, Birnbaum HG, Zhang HF, Ivanova JI, Yang E, Mallet D.

    J Manag Care Pharm. 2007 Sep;13(7):561-9.PMID: 17874862 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database.

    Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI.

    Curr Med Res Opin. 2005 Apr;21(4):535-44.PMID: 15899102 [PubMed - indexed for MEDLINE]Related articles

    17.

    Actuarial analysis of private payer administrative claims data for women with endometriosis.

    Mirkin D, Murphy-Barron C, Iwasaki K.

    J Manag Care Pharm. 2007 Apr;13(3):262-72.PMID: 17407392 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.

    Blanchette CM, Gutierrez B, Ory C, Chang E, Akazawa M.

    J Manag Care Pharm. 2008 Mar;14(2):176-85.PMID: 18331119 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Total and component health care costs in a non-Medicare HMO population of patients with and without type 2 diabetes and with and without macrovascular disease.

    Gandra SR, Lawrence LW, Parasuraman BM, Darin RM, Sherman JJ, Wall JL.

    J Manag Care Pharm. 2006 Sep;12(7):546-54.PMID: 16981800 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data